196 related articles for article (PubMed ID: 17200920)
1. Synthesis by radical cyclization and cytotoxicity of highly potent bioreductive alicyclic ring fused [1,2-a]benzimidazolequinones.
Lynch M; Hehir S; Kavanagh P; Leech D; O'Shaughnessy J; Carty MP; Aldabbagh F
Chemistry; 2007; 13(11):3218-26. PubMed ID: 17200920
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and toxicity towards normal and cancer cell lines of benzimidazolequinones containing fused aromatic rings and 2-aromatic ring substituents.
Moriarty E; Carr M; Bonham S; Carty MP; Aldabbagh F
Eur J Med Chem; 2010 Sep; 45(9):3762-9. PubMed ID: 20605274
[TBL] [Abstract][Full Text] [Related]
3. The influence of the aziridinyl substituent of benzimidazoles and benzimidazolequinones on toxicity towards normal and Fanconi anaemia cells.
Fahey K; O'Donovan L; Carr M; Carty MP; Aldabbagh F
Eur J Med Chem; 2010 May; 45(5):1873-9. PubMed ID: 20122765
[TBL] [Abstract][Full Text] [Related]
4. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
5. One-pot double intramolecular homolytic aromatic substitution routes to dialicyclic ring fused imidazobenzimidazolequinones and preliminary analysis of anticancer activity.
Fagan V; Bonham S; Carty MP; Aldabbagh F
Org Biomol Chem; 2010 Jul; 8(14):3149-56. PubMed ID: 20485753
[TBL] [Abstract][Full Text] [Related]
6. Chemistry of pyrrolo[1,2-a]indole- and pyrido[1,2-a]indole-based quinone methides. Mechanistic explanations for differences in cytostatic/cytotoxic properties.
Khdour O; Skibo EB
J Org Chem; 2007 Nov; 72(23):8636-47. PubMed ID: 17927245
[TBL] [Abstract][Full Text] [Related]
7. Advances in the Synthesis of Ring-Fused Benzimidazoles and Imidazobenzimidazoles.
Sweeney M; Conboy D; Mirallai SI; Aldabbagh F
Molecules; 2021 May; 26(9):. PubMed ID: 34064312
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents.
Gellis A; Kovacic H; Boufatah N; Vanelle P
Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567
[TBL] [Abstract][Full Text] [Related]
9. Radical reactions with 3H-quinazolin-4-ones: synthesis of deoxyvasicinone, mackinazolinone, luotonin A, rutaecarpine and tryptanthrin.
Bowman WR; Elsegood MR; Stein T; Weaver GW
Org Biomol Chem; 2007 Jan; 5(1):103-13. PubMed ID: 17164913
[TBL] [Abstract][Full Text] [Related]
10. Cyclopropyl indolequinones: mechanistic probes for bioreductive anticancer drug action.
Moody CJ; Norton CL; Slawin AM; Taylor S
Anticancer Drug Des; 1998 Sep; 13(6):611-34. PubMed ID: 9755721
[TBL] [Abstract][Full Text] [Related]
11. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antiviral and antitumor activity of 2-substituted-5-amidino-benzimidazoles.
Starcević K; Kralj M; Ester K; Sabol I; Grce M; Pavelić K; Karminski-Zamola G
Bioorg Med Chem; 2007 Jul; 15(13):4419-26. PubMed ID: 17482821
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C.
Lavergne O; Fernandes AC; Bréhu L; Sidhu A; Brézak MC; Prévost G; Ducommun B; Contour-Galcera MO
Bioorg Med Chem Lett; 2006 Jan; 16(1):171-5. PubMed ID: 16216500
[TBL] [Abstract][Full Text] [Related]
14. Incorporating Morpholine and Oxetane into Benzimidazolequinone Antitumor Agents: The Discovery of 1,4,6,9-Tetramethoxyphenazine from Hydrogen Peroxide and Hydroiodic Acid-Mediated Oxidative Cyclizations.
Conboy D; Mirallai SI; Craig A; McArdle P; Al-Kinani AA; Barton S; Aldabbagh F
J Org Chem; 2019 Aug; 84(15):9811-9818. PubMed ID: 31293163
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of heteroarenes using cascade radical cyclisation via iminyl radicals.
Bowman WR; Cloonan MO; Fletcher AJ; Stein T
Org Biomol Chem; 2005 Apr; 3(8):1460-7. PubMed ID: 15827642
[TBL] [Abstract][Full Text] [Related]
16. Barton esters for initiator-free radical cyclisation with heteroaromatic substitution.
Coyle R; Fahey K; Aldabbagh F
Org Biomol Chem; 2013 Feb; 11(10):1672-82. PubMed ID: 23361331
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic 5-aryl-1-(4-nitrophenyl)-3-oxo-1,4-pentadienes mounted on alicyclic scaffolds.
Das U; Gul HI; Alcorn J; Shrivastav A; George T; Sharma RK; Nienaber KH; De Clercq E; Balzarini J; Kawase M; Kan N; Tanaka T; Tani S; Werbovetz KA; Yakovich AJ; Manavathu EK; Stables JP; Dimmock JR
Eur J Med Chem; 2006 May; 41(5):577-85. PubMed ID: 16581158
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new benzimidazole linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates with efficient DNA-binding affinity and potent cytotoxicity.
Kamal A; Kumar PP; Sreekanth K; Seshadri BN; Ramulu P
Bioorg Med Chem Lett; 2008 Apr; 18(8):2594-8. PubMed ID: 18378445
[TBL] [Abstract][Full Text] [Related]
20. First synthesis of N-[(aziridin-2-yl)methyl]benzimidazolequinone and analysis of toxicity towards normal and Fanconi anemia cells.
O'Donovan L; Carty MP; Aldabbagh F
Chem Commun (Camb); 2008 Nov; (43):5592-4. PubMed ID: 18997962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
